Company: LGNZZ
Filing Date: 2025-04-22
Form Type: DEF 14A
Source: 0000886163-25-000025
Chunk: 59

Company: LIGAND PHARMACEUTICALS INC
Filing Date: 2025-04-22
Form: DEF 14A
Chunk 59
---
. Korenberg’s separation from the Company. This amount is included in the Stock Awards column of the Summary Compensation Table.

(13) Amounts disclosed in this row reflect the incremental fair value expense calculated in accordance with Topic 718 that was recognized in connection with the modification of the outstanding 2022 RSUs, the vesting of which was accelerated in connection with Mr. Korenberg’s separation from the Company. This amount is included in the Stock Awards column of the Summary Compensation Table.

(14) Amounts disclosed in this row reflect the incremental fair value expense calculated in accordance with Topic 718 that was recognized in connection with the modification of the outstanding 2023 RSUs, the vesting of which was accelerated in connection with Mr. Korenberg’s separation from the Company. This amount is included in the Stock Awards column of the Summary Compensation Table.

(15) Amounts disclosed in this row reflect the incremental fair value expense calculated in accordance with Topic 718 that was recognized in connection with the modification of the outstanding 2024 RSUs, the vesting of which was accelerated in connection with Mr. Korenberg’s separation from the Company. This amount is included in the Stock Awards column of the Summary Compensation Table.

48

### OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END
The following table provides information on all stock and option awards held by our named executive officers as of December 31, 2024. All outstanding equity awards are in shares of our common stock.

|                |       |     | Option Awards |        |     |        |     |                  |         |     |   |     |                |   |     |       |     |            |        |     |   |            |            |   |            |           |   |     | Stock Awards  |   |     |           |     |                                        |           |     |   |     |             |   |     |   |     |                |           |
| Name           |       |     | Number of     
 Securities    
 Underlying    
 Unexercised   
 Options (#)   
 Exercisable   |        |     |        |     | Number of        
 Securities       
 Underlying       
 Unexercised      
 Options (#)      
 Unexercisable(1) |         |     |   |     | Equity         
 Incentive Plan 
 Awards:        
 Number of      
 Securities     
 Underlying     
 Unexercised    
 Unearned       
 Options (#)    |   |     |       |